Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-003821
Filing Date
2023-03-02
Accepted
2023-03-02 16:30:28
Documents
1
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 form4-03022023_040309.html 4  
1 form4-03022023_040309.xml 4 3116
  Complete submission text file 0001415889-23-003821.txt   4412
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Michael Robert A. (Reporting) CIK: 0001699914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 23699477